Meridiem Capital Partners’s Qiagen QGEN Stock Holding History

Meridiem Capital Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5M	Buy	+369,740	New	+$13.7M	0.65%	64

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Meridiem Capital Partners's QGEN Position: Q2 2026 in Review

Meridiem Capital Partners opened a new position in Qiagen (QGEN) in Q2 2026: 369,740 shares worth $14.5M. The stake represents 0.65% of the portfolio and ranks #64 among its holdings.

336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Meridiem Capital Partners held 369,740 shares of Qiagen worth $14.5M as of Q2 2026.
Qiagen was a new Meridiem Capital Partners position in Q2 2026.
Qiagen made up 0.65% of Meridiem Capital Partners's portfolio in Q2 2026, its #64 holding.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.